StreetInsider.com News Articles

Form 4 X4 Pharmaceuticals, Inc For: Oct 16 Filed by: Craig Adam R

Mon, 19 Oct 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20261019/27203905.html

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders

Fri, 09 Oct 2026 07:00:00 -0400

BOSTON, Oct. 09, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that the Company will host a virtual Investor Day on Thursday, October 29, 2026, from 10:00 a.m. to 12:00 p.m. ET.

The Investor Day will feature discussions with X4 Pharmaceuticals management and key opinion leaders on mavorixafor as a potential treatment for chronic neutropenia. Management will review the current status of the Phase 3 4WARD clinical trial and will outline a planned Phase 2 clinical

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders

Fri, 09 Oct 2026 07:00:00 -0400

Form 8-K X4 Pharmaceuticals, Inc For: Oct 07

Thu, 08 Oct 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20261008/27167747.html

X4 Pharmaceuticals secures $150M debt facility with K2 HealthVentures

Thu, 08 Oct 2026 07:03:23 -0400

X4 Pharmaceuticals (Nasdaq: XFOR) has entered into a senior secured term loan facility of up to $150 million with K2 HealthVentures LLC, replacing a prior loan agreement, according to a press release from the Boston-based company.

The first tranche of $80 million was funded at closing and used to repay $75 million in principal and related fees under the prior loan agreement. An additional $70 million may be made available to X4 upon request, subject to K2 HealthVentures approval and other conditions.

The new facility includes a longer interest-only period and a 48-month maturity term. X4 said the funding is intended to

X4 Pharmaceuticals secures $150M debt facility with K2 HealthVentures

Thu, 08 Oct 2026 07:03:23 -0400

The new facility includes a longer interest-only period and a 48-month maturity term. X4 said the funding is intended to

X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures

Thu, 08 Oct 2026 07:00:00 -0400

- Repayment of Existing Loan Facility Completed -

- Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities -

- Expect Completion of Enrollment in Phase 3 4WARD trial by Year-End 2026 and Topline Data in H1 2028 -

BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that it has entered into a senior secured term loan facility of up to $150 million with K2 HealthVentures LLC (“K2HV”), an alternative investment firm that provides flexible,

X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures

Thu, 08 Oct 2026 07:00:00 -0400

Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: FMR LLC

Wed, 07 Oct 2026 11:47:00 -0400

si-local-file:///var/storage/secattach/20261007/27159989.html

Form 4 X4 Pharmaceuticals, Inc For: Oct 01 Filed by: KIRSKE DAVID

Mon, 05 Oct 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20261005/27148645.html

Form 144 X4 Pharmaceuticals, Inc Filed by: KIRSKE DAVID

Thu, 01 Oct 2026 20:06:00 -0400

si-local-file:///var/storage/secattach/20261001/27137700.html

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 01 Oct 2026 16:30:00 -0400

BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that, effective on September 30, 2026, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 80,000 shares of X4’s common

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 01 Oct 2026 16:30:00 -0400

Form SCHEDULE 13G X4 Pharmaceuticals, Inc Filed by: Venrock Healthcare Capital Partners III, L.P.

Mon, 21 Sep 2026 20:24:00 -0400

si-local-file:///var/storage/secattach/20260921/27086406.html

Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: PERCEPTIVE ADVISORS LLC

Fri, 14 Aug 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260814/26932870.html

Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: PERCEPTIVE ADVISORS LLC

Fri, 14 Aug 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260814/26932870.html

Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Deep Track Capital, LP

Fri, 14 Aug 2026 08:35:00 -0400

si-local-file:///var/storage/secattach/20260814/26925215.html

Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Deep Track Capital, LP

Fri, 14 Aug 2026 08:35:00 -0400

si-local-file:///var/storage/secattach/20260814/26925215.html

Form 4 X4 Pharmaceuticals, Inc For: Aug 12 Filed by: Volpone John

Thu, 13 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260813/26921209.html

Form 4 X4 Pharmaceuticals, Inc For: Aug 12 Filed by: Volpone John

Thu, 13 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260813/26921209.html

Form 4 X4 Pharmaceuticals, Inc For: Aug 12 Filed by: Craig Adam R

Thu, 13 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260813/26921098.html

Form 4 X4 Pharmaceuticals, Inc For: Aug 12 Filed by: Craig Adam R

Thu, 13 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260813/26921098.html

Form 144 X4 Pharmaceuticals, Inc Filed by: Volpone John

Thu, 13 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260813/26920486.html

Form 144 X4 Pharmaceuticals, Inc Filed by: Volpone John

Thu, 13 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260813/26920486.html

Form 144 X4 Pharmaceuticals, Inc Filed by: Craig Adam R

Thu, 13 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260813/26920473.html